Noema Pharma AG

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Tourette syndrome, basal ganglia disorder, brain disorder, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, neurodevelopmental disorder, psychiatric disorder, tic disorder	Active, not recruiting	Phase 2	2026-03-09		NCT06315751
An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.	Stomatognathic Diseases, cranial nerve neuropathy, facial nerve disorder, facial neuralgia, mouth disorder, nervous system disorder, trigeminal nerve disorder, trigeminal neuralgia	Active, not recruiting	Phase 2 / Phase 3	2026-01-23		NCT05217628

Clinical trials